| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |